Research
Lipid Nanoparticles Development
The Murthy laboratory has multiple projects focused on developing next generation LNPs. These projects focus on the development of LNPs that are non-immunogenic and have lower toxicity than traditional LNPs. In addition, we are also developing LNPs that disrupt endosomes efficiently and transfect non-liver organs.
Protein/Oligo Development
The Murthy laboratory has had a long-standing interest in developing protein and oligonucleotide delivery vectors. Current projects focus on using self-immolative linkers to conjugate delivery vectors to proteins and oligos.
Welcome to the Murthy Lab
Our laboratory is focused on developing new materials for drug delivery and molecular imaging. Current projects include delivery of CRISPR-Cas9, development of novel antibiotics and point of care diagnostic tools.
Recent News
- Congratulation to Teena Bajaj and Babak Mosavati for their recent publication in RSC Advance titled “Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning”
- Congratulation to Hesong Han and Sheng Zhao for the recent publication in Nature Biomedical Engineering titled “A microphysiological system for screening lipid nanoparticle−mRNA complexes predicts in vivo heart transfection efficacy”
- Congratulation to Hesong Han, Sheng Zhao, and Atip Lawanprasert for publishing a paper entitled “Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein” in Nature Biotechnology